22nd International Symposium on Regulatory Peptides

RegPep 2018

Advances in basic research on regulatory peptide physiology leading to accelerated translation to peptide-based therapeutics

Header image

September 22-25, 2018

Hotel Princess Mundo Imperial, Riviera Diamante, Acapulco





RegPep2018 is the 22nd Symposium of the International Regulatory Peptide Society (IRPS), an international federation of scientists committed to progress in basic research on the biology and physiology of peptides, and translation of that basic research into clinical gains and public health benefit.

RegPep2018 will be a critical meeting in the peptide field, as in previous years, by explicitly uniting basic research and clinical research in regulatory peptides. However, the emphasis on the emergence of peptides as therapeutic agents, for the 2018 conference, will create a synergism between the basic and clinical aspects of the peptide field that will potentially have a strong impact on progress in this area to the benefit of the public health in the coming years. This translational focus will be specially emphasized at RegPep2018, which will be held for the first time ever in Latin America, on Acapulco Diamante, Mexico, in September 22-25, 2018.

RegPep past meetings have been held in: Asilomar (USA, 1976), Beito (Norway, 1978), Cambridge (UK, 1980), Stockholm (Sweden, 1982), Rochester (USA, 1984), Vancouver (Canada, 1986), Shizuoka (Japan, 1988), Timmerndorfer Strand (Germany, 1990), Luewen (Belguim 1992), Santa Barbara (USA, 1994), Copenhagen (Denmark, 1996), Mackinac Island (USA, 1998), Cairns (Australia, 2000), Boston (USA, 2002), Toulouse (France, 2004), Hakone (Japan, 2006), Santa Bárbara (USA, 2009), Belfast (Ireland, 2010), Copenhagen (Denmark, 2012), Kyoto (Japan, 2014), Rouen (France, 2016).


Header image






An historical note

The history of RegPep and the International Regulatory Peptide Society can be found on its website (regulatorypeptide.org). The IRPS exists to make possible every other year the international regulatory peptide meeting called RegPep, of which RegPep2018 is the 22nd. A brief history: the first regulatory peptide discovered was secretin (by Starling and Bayliss, in 1902); the ‘prime regulatory peptide’ and the one of greatest current medical consequence, insulin, was discovered by Banting and Best in the early 1920’s. The sequence of the nine-amino acid-long hormone oxytocin, and the first laboratory synthesis, was accomplished in 1954 by du Vigneaud. Victor Mutt and others began the systematic identification of peptides of the gut in the 1960s, and established a method for detecting and chemically identifying peptides of the gut by their C-terminal amidation (about half of all regulatory peptides are amidated), that resulted in the discovery of many more biologically active peptides.

In the years since, many other peptides like CCK, VIP, and enkephalin have been discovered which, like insulin, control metabolism through regulation of cellular uptake of fuels including sugar, protein, and lipids, behavior, the proliferation of cells, the immune system, etc. Peptides represent a diverse symphony of regulators of most bodily and mental functions, and as such are a rich source for understanding human physiology and developing human therapeutics. The IRPS, and RegPep, exist to serve that purpose. The IRPS was established and held its first international conference in 1976 because physiologists and pharmacologists who knew of Mutt’s work realized that it would result in an explosion in new knowledge about regulation of human physiology by peptides, and many new therapeutic opportunities to treat human diseases of the gut and peripheral tissues. Another great breakthrough in the field came when the brain factors that control pituitary hormone secretion were discovered to be peptides, and sequenced and chemically synthesized by Schally and Guillemin and their colleagues. As more peptide sequencing by colleagues of Guillemin and Schally, and of Mutt, occurred, it was realized that many of the ‘gut’ and ‘hypophysiotropic’ peptides were also expressed in the brain, and the science of neuroendocrinology became an integral part of what is today called ‘neuroscience’.

Throughout these years, RegPep has been a constant source of intellectual renewal in the promise of peptides for understanding fundamental neuroscience and endocrinology, and focusing this knowledge clinically and, particularly in this coming year, in new drug discovery. RegPep celebrates the triad of physiology, medicine, and pharmacology in both a practical and an intellectual way. Intellectually, knowledge about new peptides in various species is of basic interest no matter in what species the initial discoveries are made. Information about the pharmacological effects of administered peptides in humans, or detection of altered peptide levels in various human diseases such as hypoparathyroidism, diabetes, epilepsy, and so forth allows confirmation of the importance of the new peptide in clinical medicine. Finally, as a practical matter, peptide actions in contributing to diseases suggest drugs that act by blocking their receptors, while peptide actions in ameliorating disease suggest drugs that act by stimulating their receptors.

Lee E. Eiden (NIH, USA, Chair of RegPep2018), Limei Zhang (UNAM, Mexico, Co-Chair of RegPep2018)






Mission statement

RegPep2018 is being convened to unite basic, translational and pharmaceutical scientists who study, and develop therapeutically, biological peptides with key physiological functions in the brain, the gut, and the cardiovascular and immune systems to affect processes of cognition and mood, digestion and metabolism, blood pressure and inflammation and surveillance of cell malignancy.

Peptides are key regulators in health and disease, including depression, anxiety, PTSD, neurodegeneration, obesity, diabetes, hypertension, allergy, autoimmune disease, reproductive disorders and cancer. Within the last five years, more peptide-based drugs have been approved by the US Food and Drug Administration for the treatment of human disease than in the previous 50 years. Helping to create a ‘revolution of opportunity’ for leveraging knowledge about peptide physiology that allows identification of novel drug targets, and the creation of innovative new drugs, is the aim of our meeting.

Accordingly, RegPep2018 will feature presentations by science leaders in the fields of peptide biology in five thematic areas (central nervous system, cardiovascular, metabolism, cancer, anti-microbials), and commentary and perspectives by academic, pharma and government leaders that collectively help guide drugs safely to final use in the clinic and in everyday medical practice.

Header image






Local organizing committee

  • Limei Zhang (President of LOC, FM-UNAM)
  • German Fajardo-Dolci (Hon. Chair and Dean of the Faculty of Medicine, UNAM)
  • Irene Durante (FM-UNAM)
  • Raúl Aguilar Roblero (IFC-UNAM)
  • Gabriela Cesarman (INCAN)
  • Vito Salvador Hernández (FM-UNAM)
  • Luis Arturo Gonzalez Nava (Chief Administrative Officer, FM-UNAM)
  • Lee E. Eiden, (Chair of RegPep2018, NIMH-IRP/NIH)
  • Header image






International advisory committee

Eiden, Lee E. (Chair, USA) Zhang, Limei (Co-Chair, México)

Aguilera, Greti (USA) Lujan, Rafael (Spain)
Antunes-Rodriguez, José (Brazil) Mahata, Sushil (USA)
Banks, William (USA) Miyata, Atsuro (Japan)
Baram, Tallie Z. (USA) Moody, Terry (USA)
Brown, Colin (New Zealand) Pemberton, Chris (New Zealand)
Chow, Billy K.C. (China) Pintér, Erika (Hungary)
Depoortere, Inge (Belgium) Pisegna, Joseph (USA)
Gainer, Harold (USA) Reglödi, Dora (Hungary)
Gozes, Illana (Israel) Russell, John A. (UK)
Hiriart, Marcia (Mexico) Seong, Jae Young (Korea)
Hökfelt, Tomas (Sweden) Shioda, Seiji (Japan)
Joseph-Bravo, Patricia (Mexico) Taché, Yvette (USA)
Kershenobich, David (Mexico) Vaudry, Hubert (France)
Kofler, Barbara (Austria) Vivas, Laura (Argentina)
Leng, Gareth (UK) Waschek, James (USA)





RegPep2018 Secretariat

  • Dr. Limei Zhang
  • Faculty of Medicine
  • National Autonomous University of Mexico
  • Av. Universidad 3000
  • Col. Universidad Nacional Autónoma de México
  • Ciudad de México, C.P. 04510, México
  • Phone: +52 55 5623 2348
  • Email: regpep2018@unam.mx
  • URL: regpep2018.facmed.unam.mx

Header image






First announcement: call for symposium/speaker proposals

Header image

Dear colleagues,

It is our great pleasure to announce the 22nd International Symposium on Regulatory Peptides, RegPep2018, under the auspice of the International Regulatory Peptide Society (IRPS) and the National Autonomous University of Mexico (UNAM), which will be held on September 22-25, 2018, at the Resort and Conference Center Princess Mundo Imperial, in the newly developed Riviera Diamante, Acapulco, Mexico.

RegPep2018 is a unique venue in which basic and clinician scientists studying the physiology and pathophysiology of peptide actions, integrated from a brain-body-behavior perspective in health and disease, can learn how their key research questions relate to therapeutics.

RegPep2018 will feature cutting-edge findings across all aspects of peptide function, in translationally relevant areas of research.

Together with the Local Organizing Committee (LOC) and the International Advisory Committee (IAC) of RegPep2018, we would like to invite you to submit symposium/speaker proposals, which will be peer-reviewed and classified as contributed talks in symposia for RegPep2018.

Participants including both speakers, and poster presenters chosen by the RegPep2018 Program Committee, will have the possibility to contribute as authors to one of two Special Issues arising from the conference to be published in Frontiers in Endocrinology/Neuroscience and in The Annals of the New York Academy of Sciences.

Proposals for symposia should be submitted to regpep2018@unam.mx, cc to limei@unam.mx and eidenl@nih.gov. Symposium proposals should include name, e-mail address and laboratory website URL of each speaker, title of each presentation, and a brief paragraph on the importance of the symposium topic to the mission and scope of RegPep2018 (regpep2018.facmed.unam.mx). We strongly recommend you to not propose more than 3 potential speakers, leaving space for contributed talks from general submissions, selected by the program sub-committee of the IAC.

You are warmly welcome to self-propose to be a speaker. In this case, please provide us your title and an abstract with at least one publication in the field of your own and other recent and/or relevant literature. Please have a look of the already existed topics for proposed symposia (apendix).

Deadline for symposium/speaker proposal/self-proposal:

31st of January 2018

Participants in selected symposia will be offered complimentary hotel accommodations and attendance at Conference Dinner, but will be expected to register in advance for RegPep2018.

Website registration opens on 15th January 2018:


Decision about acceptance of the symposium proposals will be made and communicated to proposers before February 15th, 2018.

We look forward to seeing you at RegPep2018.

  • Lee E. Eiden (NIH, USA, Chair of RegPep2018)
  • Limei Zhang (UNAM, Mexico, Co-Chair of RegPep2018 and President of LOC)
  • David Vaudry (INSERM, France, Chair of IRPS)


Suggested symposium and workshop topics so far:

  • Subcortical homeostatic circuitry modulating brain waves and behavioral adaptation
  • Neuropeptides mediating CNS neuroinflammation
  • Dynorphins and other neuropeptides and their role(s) in appetitive preference and cognition
  • Evolution of peptide and peptide receptor structure and function
  • Creating pre-competitive consortia for peptide proof-of-concept for CNS disease
  • Neuropeptides, fear circuits, and PTSD
  • Extrahypothalamic functions of magnocellular neurons: optogenetics, genetics, development
  • Bioinformatics-based peptide discovery in CNS
  • Circadian coordination of brain and pituitary function
  • Neuropeptides and brain edema
  • Invertebrate models of peptide regulation of behaviour
  • CRH and hippocampal neurodegeneration in stress
  • PACAP, atherosclerosis and ApoE
  • Pain peptide pathways and chronic brain inflammation
  • Peptide translation for basic scientists: micropharma and academic research
  • Peptide drug development: strategies from bench and clinic to approval
  • Peptoids: building bridges to GPCR- and oligomerization-based drugs
  • Chromogranins and vascular, immune, and metabolic regulation
  • Peptide markers for proliferative and inflammatory disease
  • Development of peptide-based therapeutics for pancreatic disease
  • Peptides and their receptors as oncotargets
  • Neuropeptide signaling and protection from central and peripheral ischemia
  • Gut-brain axis in inflammation
  • Disorders of peptide folding and processing
  • Biased and canonical signalling to peptide-activated GPCRs
  • Neuropeptides and migraine-current translational perspectives
  • The beta-amyloid interactome
  • Peptide penetration of the blood-brain-barrier
  • Hypothalamic peptides and feeding behaviour
  • Peptides and hypothalamic control of social behaviour
  • Neuropharmacology of vasopressin and oxytocin: physiology and behaviour
  • Opiate peptides and addiction
  • Central and peripheral control of cardiovascular function
  • NPY, epilepsy and hippocampal function

Additional topic suggestions are welcome. The Program Committee will announce preliminary program in January 2018.






Flyer of RegPep 2018


Header image

Click flyer to enlarge






Scientific program

Preliminary scientific program (last update 15th January 2018)


Header image

Click program to enlarge

Plenary Speakers

  • (Listed in alphabetic order)


  • Laura Bohn (Script Institute, Florida, USA), 2018 Victor Mutt Awardee and Lecturer
  • Refining Opioid Receptor Signaling to Improve the Therapeutic Index

  • Jean-Louis Charli (UNAM, México)
  • Peptide-degrading enzymes and the control of peptide action in vivo

  • Gareth Leng (University of Edinburgh, UK)
  • The heart of the brain: the hypothalamus and its hormones

  • Robert C. Malenka (Stanford University, USA)
  • Oxytocinergic gating of social reward

  • Andrew V. Schally (Department of Veterans Affairs and University of Miami, USA)
  • Hypothalamic hormones; from neuroendocrinology to therapy of cancer and other diseases and conditions



  • (Listed provisionally in alphabetic order of the chairs)
  • Clock mechanisms of mammalian suprachiasmatic nucleus: From peptide to network interactions
  • Chair: Raúl Aguilar-Roblero (UNAM, Mexico)
  • Speakers:
  • Raúl Aguilar Roblero: The molecular circadian oscillator and circadian firing patterns in SCN neurons
  • Charles Allen (OHSU, USA): TBA
  • Christopher Colwell (UCLA, USA): The role of neuropeptides in the photic regulation of the circadian system.
  • Hugh Piggins (Manchester, UK): Intrinsic and extrinsic neuropeptide signaling in the suprachiasmatic circadian pacemaker
  • Rae Silver (Columbia University, USA): TBA
  • Neuropeptide regulation of stress and its consequences
  • Co-Chairs: Greti Aguilera (NIH, USA) and James P. Herman (Univ. Cincinnati, USA)
  • Speakers:
  • James P. Herman: Regulation of Stress Integration by Central Glucagon-like Peptide 1 Circuits
  • Eric G. Krause (Univ. Florida, USA): Central Angiotensin II and its role in stress responding
  • Jam Hammack (Univ. Vermont, USA): Involvement of PACAP in stress-induced behavioral responses
  • Jan Deussing (Max Plank Institute for Psychiatry, Munich, Germany): Role of CRH in stress adaptation
  • Peptide penetration of the blood-brain-barrier
  • Chair: William A. Banks (University of Washington, Seattle, USA)
  • Speakers:
  • William A. Banks: Understanding the nature of the ‘peptide’ blood-brain barrier
  • Patricia Grasso (Albany Medical Colege, USA): TBA
  • Neuropeptides and social behavior
  • Chair: Tallie Z. Baram (UC Irvine, USA)
  • Speakers:
  • Tallie Z. Baram: CRH and development of the pleasure/reward circuitry
  • Inga Neumann (Univ. Regensburg, FRG): Oxytocin and neuropeptide S in social behavior
  • W. Scott Young III (NIMH, USA): Vasopressin and social memory
  • Peptides in homeostatic hypothalamic circuits
  • Chair: Ruud M. Buijs (UNAM, México)
  • Speakers:
  • Ruud Buijs: TBA
  • Valerie Simonneaux (Strasbourg, France): TBA
  • The language of stress: neuropeptides and concerted CNS signaling
  • Chair: Lee E Eiden (NIMH-IRP, NIH, USA)
  • Speakers:
  • Xiao-Dong Wang (Zhejiang University, China): Neuropeptides and calbindin in stress-related disorders
  • Ki Ann Goosens (MIT, Massachusetts, USA): Ghrelin and resilience to chronic stress
  • Neuropeptide function in fear circuits
  • Chair: Francesco Ferraguti (Med. Univ. Innsbruck, Austria)
  • Speakers: To be announced
  • Presentation of Self-Peptides In The Thymus: An Essential Event Of Life
  • Chair: Vincent Geenen (University of Liege Medical School, Belgium)
  • Speakers:
  • Vincent Geenen: Historical introduction to the thymus and concept of immune Self-tolerance
  • Georg Holländer (University of Basel, Switzerland and University of Oxford, UK): The thymus: epigenetic control of the molecular mirror of Self.
  • Hiroyuki Takaba (University of Tokyo, Japan): Distinct features of Fezf2-induced promiscuous gene expression in the thymus
  • Neuropeptides and neurodegeneration
  • Co-Chairs: Illana Gozes (Tel Aviv Univ., Israel) and Seiji Shioda (Hoshi Univ, Japan).
  • Speakers:
  • Illana Gozes: VIP and PACAP to ADNP and NAP: Microtubule Neuroprotection in the ADNP syndromic Autism
  • Seiji Shioda: PACAP, stem cells and neuroprotection, spinal injury and stroke
  • Dora Reglödi (Univ. Pecs, Hungary): PACAP and retinal neuroprotection
  • Stephen Salton (Mount Sinai Univ, USA): VGF–derived fragment for neuroprotection in Alzheimer’s disease
  • Extrahypothalamic functions of magnocellular neurons: optogenetics, development and behavior
  • Chair: Valery Grinevich (Univ. Heidelberg, Germany)
  • Speakers:
  • Valery Grinevich: Oxytocinergic circuits of the amygdala: finding points of intervention for pain and pleasure
  • David Murphy (Univ. Bristol, UK): Linkages between osmoregulation and ingestive behaviors are encoded in vasopressinergic-dynorphinergic projections from hypothalamus to amygdala
  • Alexa Veneema (Michigan State Univ., USA): Vasopressin, oxytocin, social behaviors and targeting of social neuropathologies
  • Limei Zhang (UNAM, Mexico): Vasopressin projections to habenula and modulation by sex steroids: control of response to aversive stimuli in mammals
  • Control of energy balance by hypothalamic peptides
  • Chair: Patricia Joseph (UNAM, Mexico)
  • Speakers: to be announced
  • Peptidergic regulation of immune cell activity
  • Chair: Barbara Kofler (Paracelsus Med. Univ., Salzburg, Austria)
  • Speakers: to be announced
  • Drug design for the apelin receptor across diverse pathophysiological indications: Peptide drug development: strategies from bench and clinic to approval
  • Co-Chairs: Catherine Llorens-Cortes (Collège de France, Paris, France) and Eric Marsault (Université de Sherbrooke, Sherbrooke, Canada)
  • Speakers:
  • Gavin Oudit (University of Alberta, Edmonton, Canada): Heart failure
  • Catherine Llorens-Cortes: Water homeostasis and renal applications
  • Eric Marsault: Medicinal chemistry and biased signaling
  • Contemporary approaches to studying peptidergic neurones
  • Chair: Mike Ludwig (Univ. Edinburgh, UK)
  • Mike Ludwig: TBA
  • Javier Stern (Georgia State University, USA): TBA
  • Colin Brown (University of Otago, NZ): TBA
  • Jeff Tasker (Tulane University, USA): TBA
  • Vito S. Hernández (UNAM, México): TBA
  • Chromogranin- and other protein-derived bioactive peptides: cardiovascular, immune, endocrine and metabolic functions
  • Chair: Sushil Mahata (UCSD, USA)
  • Speakers: to be announced
  • Neuropharmacology of vasopressin and oxytocin: physiology and behaviour
  • Chair: Maurice Manning (Univ. Toledo, Ohio, USA)
  • Speakers:
  • Maurice Manning: TBA
  • Bice Chini (CNR Institute of Neuroscience, Milan, Italy): TBA
  • Gilles Guillon (IGF, Montpellier, France): TBA
  • Peptides and their receptors as oncotargets
  • Chair: Terry Moody (NCI, NIH, USA)
  • Speakers:
  • Gwen Murphy (NCI, NIH, USA): Neuropeptides and gastric cancer
  • Terry Moody: Bombesin receptors regulate transactivation of receptor tyrosine kinases in lung cancer
  • Jill Smith (Georgetown University, USA): CCK receptors in pancreatic cancer
  • Matthew Thakur (Thomas Jefferson Univ., USA): Imaging of prostate cancer using VIP/PACAP analogs.
  • Neuroendocrine disruption: focus on peptidergic systems
  • Co-Chairs: GianCarlo Panzica (Università di Torino) and Diego Perez-Tilves (Univ. Cincinatti, USA)
  • Speakers:
  • GianCarlo Panzica: Effects of metabolic distrupting chemicals (MDCs) on peptidergic circuits controlling feeding behaviour and metabolism.
  • Diego Perez-Tilves: TBA
  • Nesfatin-1: Update on a pleiotropic peptide
  • Co-Chairs: Andreas Stengel (Univ. Tübingen, Germany) and Yvette Taché (UCLA, USA)
  • Speakers:
  • Tomas Brzozowski (Cracow, Poland): Nesfatin and regulation of inflammation
  • Tobias Hoffman (Berlin, Germany): Role in emotional processing
  • Masatomo Mori (Gunma, Japan): Gaps in knowledge - what should be addressed next?
  • Suraj Unniappan (Sastatchewan, Canada): Blood glucose homeostatic control by nesfatin-1
  • Andreas Stengel: Role of nesfatin in food intake regulation
  • Neuropeptides in headache, inflammation and neuroinflammatory pain: Basic science to clinical trials
  • Chair: James A. Waschek (UCLA, USA)
  • Speakers:
  • Faisal Amin (Univ. of Copenhagen): PACAP and migraine
  • Andrew Russo (Univ. Iowa, USA): CGRP and migraine therapy
  • Ichiro Takasaki (Univ. of Toyama :Japan): Neuropathic pain, migraine, and PACAP receptor (PAC1) antagonists
  • James A. Waschek: VIP, PACAP and autoimmune neuroinflammatory disease
  • CART: reward, addiction, and neuroendocrine pathways
  • Chair: Nils Wierup (Lund University, Sweden)
  • Speakers: to be announced
  • Allosteric modulation at the N-terminal domain of class B GPCRs
  • Chair: Rhongjie Yu (Jinan Univ. Guangzhou, Guangdong, China)
  • Speakers:
  • Rongjie Yu: TBA
  • Huahyuan Zhang (Guangdong Medical Univ., Dongguan, Guangdong, China)

  • Note: the call is still open till Jan 31st, 2018; you are welcome to propose either to integrate to the existing symposia or suggesting new timely topics.



  • (Listed provisionally in alphabetic order of the chairs)
  • Creating pre-competitive consortia for peptide proof-of-concept for CNS disease; micropharma navigation of the peptide-based drug investigation/approval process; peptide translation for basic scientists
  • Chair: William Z. Potter (NIMH, NIH, USA)
  • How to improve peptide delivery for possible clinical application
  • Chair: David Vaudry (INSERM, France)

    Peptide Pioneers: A Roundtable featuring historical and future perspectives by leaders in the field

    Panel Speakers: to be announced


    Registration fee for all conference participants include:

  • Participation in all scientific sessions.
  • Printed program and abstract book of RegPep2018.
  • Welcome reception party.
  • Three lunches.
  • Transportation to and from the airport to conference venue.
  • Note: the registration fee does not include the conference dinner / party, which will have a cost of $50 USD.

    Early Bird (before 15th March 2018)*** Regular (16th March to 31st August 2018) On site (from 1st September 2018)
    Industry / Government delegate 500 USD 600 USD 660 USD
    Investigator * 400 USD 500 USD 560 USD
    Postdoctoral fellow *,** 300 USD 400 USD 460 USD
    Student *,** 200 USD 300 USD 360 USD
    Guest **** 100 USD 100 USD 100 USD


    * Participants from Latin-American and other developing countries holding or participating in a government or institution funded research project in the last 3 years can apply for a reduced fee (40%). Please send an email to regpep2018@unam.mx with supporting documentation and we will send you a new link for registration with the reduced fee.

    ** Please send an email to validate your trainee status.

    *** Travel award applicants should register and submit your application before this deadline.

    **** Guests are welcome to join the welcome reception and the lunch but are not expected to attend the scientific sessions. The cost of $50 USD also applies to guests for the conference dinner / party.

    Registration to RegPep2018

    Please screen-print the receipt of your payment from PayPal and email to regpep2018@unam.mx with subject field "regpep2018 registration fee: yourfirstname_yourfamilyname_yourinstitution". This insures proper notation of your registration in the records of UNAM, our sponsoring institution





    Hotel Information

    Hotel booking through the RegPep2018 Secretariat will be opened on 15th January 2018.*


    * Please note that the Princess Mundo Imperial, a 5-star resort and conference center, has offered us attractive prices, and also to respect those prices for 3 days prior and 3 days after the RegPep2018. The payment will be made through the Faculty of Medicine, UNAM - there will not be any 3rd party managing this issue. We would like to ask you for your kind cooperation by booking through the RegPep2018 Secretariat that would facilitate us, your academic peers, to organize efficiently the RegPep2018. If you would prefer to use a travel agency, please let us know your booking. The reason for this petition is that we have made a commitment for a minimum number of room occupancy for the usage of meeting facilities.







    Abstract submission

    Submit your abstract via email (regpep2018@unam.mx), together with a copy of the PayPal receipt of your registration.

    Please format the abstract as follows:

      Abstract must fit on one letter size page
      Title of the abstract should be in Times New Roman, Bold, 14pt
      Underline presenting author
      Body of the abstract should be in Times New Roman 12pt
      Up to three optional references are accepted

    Important deadlines:

    15th of March 2018: abstracts submitted by this date will be evaluated collegially by Program Committee of the IAC for contributed talks selection and for travel awards (these cover the awardee's local transportation and accommodations including hotel and meals).

    30th June 2018: abstract submission closes.







    Speakers to date...

    Speaker Country Institution
    Charles Allen USA Oregon Health Sciences University
    Faisal Amin Denmark University of Copenhagen
    Raúl Aguilar-Roblero México UNAM, Mexico City
    Greti Aguilera USA NIH, Bethesda
    William A. Banks USA University of Washington, Seattle
    Tallie Z. Baram USA University of California-Irvine
    Laura Bohn USA Scripps Institute, Jupiter
    Tomas Brzozowski Poland Cracow
    Ruud M. Buijs México UNAM, Mexico City
    Jean-Louis Charli México UNAM, Cuernavaca
    Bice Chini Italy CNR Institute of Neuroscience, Milan
    Christopher Colwell USA University of California-Los Angeles
    Inge Depoortere Belgium TARGID, Leuven
    Jan Deussing Germany Max-Planck Institute, Munich
    Francesco Ferraguti Austria Med. Univ. Innsbruck
    Vincent Geenen Belgium University Hospital of Liege
    Ki Ann Goosens USA MIT, Massachusetts
    Gilles Guillon France IGF, Montpellier
    Illana Gozes Israel Tel Aviv University
    Patricia Grasso USA Albany Medical Colege
    Valery Grinevich Germany Max-Planck Institute, Heidelberg
    Jom Hammack USA University of Vermont
    James P. Herman USA University of Cincinnati
    Tobias Hoffman Germany Berlin
    Vito Hernández México UNAM, Mexico City
    Patricia Joseph México UNAM Cuernavaca
    Barbara Kofler Austria Paracelsus Medical Univ, Salzburg
    Eric G. Krause USA University of Florida, USA
    Gareth Leng UK University of Edinburgh
    Mike Ludwig UK University of Edinburgh
    Sushil Mahata USA University of California-San Diego
    Robert C. Malenka USA Stanford University
    Maurice Manning USA University of Toledo, Ohio
    Terry Moody USA NCI, NIH, Bethesda
    Masatomo Mori Japan Gunma
    David Murphy UK University of Bristol
    Gwen Murphy USA NCI, NIH, Bethesda
    Inga D. Neumann Germany University of Regensburg
    Diego Perez-Tilve USA University of Cincinnati, Ohio
    Hugh Piggins UK University of Manchester
    Erika Pintér Hungary University of Pecs
    Joseph Pisegna USA University of California-Los Angeles
    William Z. Potter USA NIMH, NIH, Bethesda
    Dora Reglödi Hungary University of Pecs
    Andrew Russo USA University of Iowa
    Stephen Salton USA Mount Sinai University
    Matthew Thakur USA Thomas Jefferson University,Pensilvania
    Suraj Unniappan Canada Sastatchewan
    Andrew V. Schally USA University of Miami
    Seiji Shioda Japan Showa University, Tokyo
    Rae Silver USA Columbia University, New York
    Valerie Simonneaux France INCI, Strasbourg
    Jill Smith USA Georgetown University, Washington, D.C.
    Andreas Stengel Germany University of Tübingen
    Ichiro Takasaki Japan University of Toyama
    Yvette Taché USA University of California-Los Angeles
    David Vaudry France University of Rouen
    Alexa Veneema USA Michigan State University
    James A. Waschek USA University of California-Los Angeles
    Nils Wierup Sweden Lund University
    W. Scott Young USA NIMH, Bethesda
    Rhongjie Yu China Jinan University Guangzhou, Guangdong
    Xiao-Dong Wang China Zhejiang University
    Huahyuan Zhang China Guangdong Medical University
    Limei Zhang México UNAM, Mexico City

    Gallery Mexico City

    Header image

    Your Mexican colleagues look forward to welcome you in RegPep2018! Left to right: Jean-Louis Charli, Vito Hernández, (Lee E.Eiden, NIH, USA), Limei Zhang, Raúl Aguilar-Roblero and Patrícia Joseph-Bravo, January 11, 2018





    Webmasters: Vito Hernández & Hernán Barrio

    Last update: January 19th, 2018